ARDS logo

Aridis Pharmaceuticals (ARDS)

Profile

Full Name

Aridis Pharmaceuticals, Inc.

Ticker Symbol

ARDS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 14, 2018

Indexes

Not included

Website

http://www.aridispharma.com

Employees

37

Key Details

Price

$0.00(0.00%)

Market cap

$4457.40(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.62(+57.03% YoY)

PE ratio

-

Next earnings date

Apr 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.00
ARDS price is $0.00

30-Day Relative Volume

3.43
ARDS 30-day relative volume is 3.43

Price Performance

Price Most recent change

0%
ARDS {parameterFullLabel} has remained unchanged on Apr 11, 2025

Price YTD change

0%
ARDS {parameterFullLabel} has remained unchanged since January 1st

Price 1-year change

-99.86%
ARDS price is down -99.86% year-on-year

Price 3-year change

-99.99%
ARDS price is down -99.99% over the past 3 years

Price Range

Price All-time high

$13.85
ARDS price is currently -100.00% below its historical high of $13.85

Price 3-year low

$0.00
ARDS price is currently at its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$4457.40
ARDS market capitalization is $4457.40

Market cap 3-year change

-99.98%
ARDS market capitalization is down -99.98% over the past 3 years

Market cap All-time high

$110.89M
ARDS market capitalization is currently -100.00% below its historical high of $110.89 million

Market cap sector rank

1.07%
ARDS market capitalization is higher than 1.07% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
ARDS {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

+151.81%
ARDS shares outstanding is up +151.81% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.76
ARDS beta is 0.76

200-day SMA

$0.01
ARDS price is currently -98.08% below its 200-day simple moving average

50-day SMA

$0.00
ARDS price is currently equal to its 50-day simple moving average

RSI

50.00
ARDS 14-day relative strength index is 50.00

Volume

3.43
ARDS 30-day relative volume is 3.43

ATR

$0.00
ARDS average true range is $0.00

10-day Historical Volatility

0.00%
ARDS 10-day historical volatility is 0.00%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ARDS annual revenue value is unknown

Revenue Analysts estimate

$21.40M
ARDS annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
ARDS annual revenue 1-year change is unknown

Revenue Sector rank

-
ARDS annual revenue is unknown

EPS

EPS

-$1.62
ARDS annual earnings per share is -$1.62

EPS Analysts estimate

-
ARDS annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+57.03%
ARDS annual earnings per share is up +57.03% year-on-year

EPS Sector rank

43.44%
ARDS annual earnings per share is higher than 43.44% of companies in Healthcare sector

Profit

Gross profit

-
ARDS annual gross profit value is unknown

Gross margin

-
ARDS annual gross profit margin value is unknown

Operating profit

-$29.99M
ARDS annual operating income is -$29.99 million

Operating margin

-
ARDS annual operating profit margin value is unknown

Net income

-$30.37M
ARDS annual net profit is -$30.37 million

Net margin

-
ARDS annual net profit margin value is unknown

Expenses

Total expenses

$29.99M
ARDS annual total expenses is $29.99 million

Operating expenses

$29.99M
ARDS annual total operating expenses is $29.99 million

Cost of goods sold

-
ARDS annual cost of goods sold value is unknown

Selling, general & administrative expenses

$7.16M
ARDS annual SGA is $7.16 million

Depreciation and amortization

$487.00K
ARDS annual depreciation & amortization is $487.00 thousand

Interest expense

-
ARDS annual interest expense value is unknown

Income tax

-
ARDS annual income tax value is unknown

EBIT & EBITDA

EBIT

-$29.99M
ARDS annual earnings before interest & taxes is -$29.99 million

EBITDA

-$29.51M
ARDS annual EBITDA is -$29.51 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$14.70M
ARDS annual total assets is $14.70 million

Non current assets

$3.07M
ARDS annual long term assets is $3.07 million

Current assets

$11.63M
ARDS annual total current assets is $11.63 million

Cash and cash equivalents

$4.88M
ARDS annual cash & cash equivalents is $4.88 million

Accounts receivable

$1.00M
ARDS annual accounts receivable is $1.00 million

Inventory

-
ARDS annual inventory value is unknown

Liabilities

Total liabilities

$38.93M
ARDS annual total liabilities is $38.93 million

Long term liabilities

$2.03M
ARDS annual total long term liabilities is $2.03 million

Current liabilities

$36.90M
ARDS annual total current liabilities is $36.90 million

Accounts payable

$2.31M
ARDS annual accounts payable is $2.31 million

Debt

Total debt

$6.13M
ARDS annual total debt is $6.13 million

Total debt 1-year change

+2.54%
ARDS annual total debt is up +2.54% year-on-year

Long term debt

$1.29M
ARDS annual long term debt is $1.29 million

Short term debt

$4.84M
ARDS annual short term debt is $4.84 million

Equity & Capital

Shareholders equity

-$24.23M
ARDS annual stockholders equity is -$24.23 million

Book value

-$24.23M
ARDS annual book value is -$24.23 million

Retained earnings

-$195.67M
ARDS annual retained earnings is -$195.67 million

Working capital

-$25.27M
ARDS annual working capital is -$25.27 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$29.13M
ARDS annual cash flow from operations is -$29.13 million

Cash from operations 1-year change

-26.99%
ARDS annual cash flow from operations is down -26.99% year-on-year

Cash from investing

-$82.00K
ARDS annual cash flow from investing activities is -$82.00 thousand

Cash from investing 1-year change

+84.53%
ARDS annual cash flow from investing activities is up +84.53% year-on-year

Cash from financing

$14.78M
ARDS annual cash flow from financing activities is $14.78 million

Cash from financing 1-year change

-57.43%
ARDS annual cash flow from financing activities is down -57.43% year-on-year

CAPEX

CAPEX

-
ARDS annual capital expenditures value is unknown

CAPEX 1-year change

-
ARDS annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$29.21M
ARDS annual free cash flow is -$29.21 million

Free cash flow 1-year change

-24.47%
ARDS annual free cash flow is down -24.47% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ARDS annual gross profit margin value is unknown

Operating margin

-
ARDS annual operating profit margin value is unknown

Net margin

-
ARDS annual net profit margin value is unknown

ROA & ROE

ROA

-206.68%
ARDS annual return on assets is -206.68%

ROE

125.33%
ARDS annual return on equity is 125.33%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ARDS price to earnings ratio value is unknown

PE ratio Sector rank

-
ARDS price to earnings ratio is unknown

PB Ratio

PB ratio

0.00
ARDS price to book ratio is 0.00

PB ratio Sector rank

16.69%
ARDS price to book ratio is higher than 16.69% of companies in Healthcare sector

PS Ratio

PS ratio

-
ARDS price to sales ratio value is unknown

PS ratio Sector rank

-
ARDS price to sales ratio is unknown

Enterprise value

Enterprise value

$4.81M
ARDS enterprise value is $4.81 million

Enterprise value Sector rank

19.74%
ARDS enterprise value is higher than 19.74% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-7.60
ARDS EV/EBITDA is -7.60

EV/EBITDA Sector rank

13.38%
ARDS EV/EBITDA is higher than 13.38% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.32
ARDS annual current ratio is 0.32

Quick ratio

-
ARDS annual quick ratio value is unknown

Leverage

Debt to equity

-0.25
ARDS annual debt to equity ratio is -0.25

Interest coverage ratio

-
ARDS annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ARDS piotroski f-score value is unknown

Altman Z-Score

-
ARDS altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Nov 6, 23 HC Wainwright & Co.
Buy
Oct 20, 23 HC Wainwright & Co.
Buy
Jan 26, 23 HC Wainwright & Co.
Buy
Aug 16, 22 Maxim Group
Hold
Jul 20, 21 HC Wainwright & Co.
Buy
May 15, 20 HC Wainwright & Co.
Buy
May 15, 20 H.C. Wainwright
Buy
Feb 19, 20 Roth Capital
Buy
Dec 30, 19 HC Wainwright & Co.
Buy
Dec 30, 19 H.C. Wainwright
Buy

Institutional Ownership

Similar stocks

CALA logo
Calithera Biosciences (CALA)
STAB logo
Statera Biopharma (STAB)
NMRD logo
Nemaura Medical (NMRD)
BIMI logo
BIMI International Medical (BIMI)
CMRA logo
Comera Life Sciences Holdings (CMRA)
THMO logo
ThermoGenesis Holdings (THMO)
AMPE logo
Ampio Pharmaceuticals (AMPE)
VIVE logo
Viveve Medical (VIVE)
EFTR logo
eFFECTOR Therapeutics (EFTR)
  • What is the ticker symbol for Aridis Pharmaceuticals?
  • Does Aridis Pharmaceuticals pay dividends?
  • What sector is Aridis Pharmaceuticals in?
  • What industry is Aridis Pharmaceuticals in?
  • What country is Aridis Pharmaceuticals based in?
  • When did Aridis Pharmaceuticals go public?
  • Is Aridis Pharmaceuticals in the S&P 500?
  • Is Aridis Pharmaceuticals in the NASDAQ 100?
  • Is Aridis Pharmaceuticals in the Dow Jones?
  • When was Aridis Pharmaceuticals's last earnings report?
  • When does Aridis Pharmaceuticals report earnings?
  • Should I buy Aridis Pharmaceuticals stock now?

What is the ticker symbol for Aridis Pharmaceuticals?

The ticker symbol for Aridis Pharmaceuticals is NASDAQ:ARDS

Does Aridis Pharmaceuticals pay dividends?

No, Aridis Pharmaceuticals does not pay dividends

What sector is Aridis Pharmaceuticals in?

Aridis Pharmaceuticals is in the Healthcare sector

What industry is Aridis Pharmaceuticals in?

Aridis Pharmaceuticals is in the Biotechnology industry

What country is Aridis Pharmaceuticals based in?

Aridis Pharmaceuticals is headquartered in United States

When did Aridis Pharmaceuticals go public?

Aridis Pharmaceuticals's initial public offering (IPO) was on August 14, 2018

Is Aridis Pharmaceuticals in the S&P 500?

No, Aridis Pharmaceuticals is not included in the S&P 500 index

Is Aridis Pharmaceuticals in the NASDAQ 100?

No, Aridis Pharmaceuticals is not included in the NASDAQ 100 index

Is Aridis Pharmaceuticals in the Dow Jones?

No, Aridis Pharmaceuticals is not included in the Dow Jones index

When was Aridis Pharmaceuticals's last earnings report?

Aridis Pharmaceuticals's most recent earnings report was on Nov 6, 2023

When does Aridis Pharmaceuticals report earnings?

The next expected earnings date for Aridis Pharmaceuticals is Apr 15, 2025

Should I buy Aridis Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page